CHALLENGES FACED in TRANSFERRING ECONOMIC EVALUATIONS to MIDDLE INCOME COUNTRIES

International Journal of Technology Assessment in Health Care

Volumn 31, Issue 6, 2016, Pages 442-448

  Drummond, Michael ^a   Augustovski, Federico ^b   Kaló, Zoltán ^c   Yang, Bong Min ^d   Pichon Riviere, Andres ^b   Bae, Eun Young ^e   Kamal Bahl, Sachin ^f  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d Seoul National University   (South Korea)

^e Gyeongsang National University   (South Korea)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cost effectiveness analysis; Health technologies; Reimbursement

Indexed keywords

COST EFFECTIVENESS; COSTS; DECISION MAKING; ECONOMIC ANALYSIS; HEALTH;

CENTRAL AND EASTERN EUROPE; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRIES; ECONOMIC EVALUATIONS; GROSS DOMESTIC PRODUCTS; HEALTH TECHNOLOGY; MIDDLE-INCOME COUNTRIES; REIMBURSEMENT;

COST BENEFIT ANALYSIS;

ASIA; CLINICAL ARTICLE; CONSENSUS DEVELOPMENT; DEVELOPED COUNTRY; EASTERN EUROPE; ECONOMIC EVALUATION; GROSS NATIONAL PRODUCT; HEALTH STATUS; HUMAN; INTERVIEW; MODEL; ORGANIZATION; PRACTICE GUIDELINE; SCIENTIST; SOUTH AND CENTRAL AMERICA; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PRACTICE; DECISION MAKING; ECONOMICS; EUROPE; HEALTH SERVICES RESEARCH; ORGANIZATION AND MANAGEMENT;

ASIA; DECISION MAKING; DEVELOPED COUNTRIES; EUROPE; GROSS DOMESTIC PRODUCT; HEALTH SERVICES RESEARCH; HUMANS; INTERVIEWS AS TOPIC; LATIN AMERICA; PRACTICE PATTERNS, PHYSICIANS'; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84960899803     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462315000604     Document Type: Article

References (16)

1. Drummond MF, Twenty years of using economic evaluations for drug reimbursement decisions. What has been achieved? J Health Polit Policy Law. 2013;38:1081-1102.
2. Drummond MF, Sculpher MJ, Claxton K, Torrance GW, Stoddart GL. Methods for the economic evaluation of health care programmes: Fourth edition. Oxford: Oxford University Press; 2015.
3. Tsuchiya A, Williams A. Welfare economics and economic evaluation. In: Drummond M, McGuire A, eds. Economic evaluation in health care: Merging theory with practice. Oxford: Oxford University Press; 2001.
4. Coast J. Is economic evaluation in touch with society's health values? BMJ. 2004;329:1233-1236.
5. Shiell A, Hawe P, Gold L. Complex interventions or complex systems. Implications for economic evaluation. BMJ. 2008;336:1281.
6. Drummond M, Barbieri M, Cook J, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12:409-418.
7. Barbieri M, Drummond M, Rutten F, et al. What do international pharmacoeconomic guidelines say about economic data transferability? Value Health. 2010;13:1028-1037.
8. Caro JJ, Briggs AH, Siebert U, et al. Modeling good research practices-overview: A report of the ISPOR-SMDM modeling good research practices task force-1. Value Health. 2012;15:796-803.
9. Eunethta. (2013) EuNetHTA adaptation toolkit http://www. eunethta. eu/sites/5026. fedimbo. belgium. be/files/EUnetHTA-adptation- toolkit-2011%20version%205. pdf (accessed December 5, 2013).
10. Goeree R, Burke N, O'Reilly D, et al. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23:671-682.
11. Augustovski F, Iglesias C, Manca A, et al. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27:919-929.
12. Pichon-Riviere A, Augustovski F, Garca Mart? S, Sullivan SD, Drummond M. Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers. Int J Technol Assess Health Care. 2012;28:180-186
13. Neumann PJ, Drummond MF, Jönsson B, et al. Are key principles for improved health technology assessment supported and used by health technology assessment organizations? Int J Technol Assess Health Care. 2010;26:71-78.
14. Drummond MF, Neumann PJ, Jönsson B, et al. Can we reliably benchmark health technology assessment organizations? Int J Technol Assess Health Care. 2012;28:159-165.
15. Jansen JP, Fleurence R, Devine B, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on indirect treatment comparisons good research practices: Part 1. Value Health. 2011;14:417-428.
16. Hoaglin DC, Hawkins N, Jansen JP, et al. Conducting indirect-treatmentcomparison and network-meta-analysis studies: Report of the ISPOR Task Force on indirect treatment comparisons good research practices-Part 2. Value Health. 2011;14:429-437.